BEIJING, Jan. 12, 2015 (GLOBE NEWSWIRE) -- Dehaier Medical Systems Ltd. (Nasdaq:DHRM) ("Dehaier" or the "Company"), which develops, markets and sells medical devices and wearable sleep respiratory products in China, today announced that its sleep respiratory solution systems have been adopted by Ciming Aoya Hospital, a subsidiary of Ciming Healthcare Group (the "Ciming Group"). The Company's wearable sleep respiratory solution features a full range of innovative products and services, including working stations, cloud-based diagnostic and analysis software, watch-sized sleep diagnostic and monitoring devices, and PPG sensors. Established in 2004, the Ciming Group is one of the three largest physical examination chains in China and provides comprehensive screening, diagnostic, treatment, and health management services for nearly two million people each year through its 83 subsidiaries and affiliates and over 100 third party cooperative organizations across China. Dehaier's wearable sleep respiratory solution system allows patients at Ciming Aoya Hospital to take sleep tests in the comfort of their own homes, instead of traditionally spending the night in the test lab or in the hospital. This comprehensive and cost effective solution is more efficient than, and as accurate as, traditional polysomnography (PSG) based sleep tests. A number of Ciming's patients have recently used Dehaier's wearable sleep monitoring products, and these products have helped the hospital diagnosing several patients with moderate-to-severe obstructive sleep apnea ("OSAS") and refer them to specialist hospitals for timely treatment. As Ciming's patients learn more about the direct and indirect health risks of OSAS, the demand for sleep tests based on Dehaier's wearable sleep respiratory technology will increase, and the Company hopes to extend Dehaier's innovative system and solutions to Ciming Group's other facilities in the future. Mr. Ping Chen, Chief Executive Officer of Dehaier, stated, "The physical examination market in China is a RMB 60 billion market with high growth potential, thanks to China's rapidly expanding middle class, much improved average life expectancy, and aging population. We expect to benefit tremendously from this favorable market trend by working with leading physical examination chains like the Ciming Group and look forward to expanding our cooperation with the Ciming Group in coming years."
About Ciming GroupEstablished in September 2004, Ciming Healthcare Group (the "Ciming Group") is a pioneer in providing high-end, membership-based physical examination and health management services in China. Through its 83 fully owned or affiliated physical examination centers and hospitals and over 100 third party cooperative organizations, Ciming provides physical screening, diagnostic, treatment, and health management services for nearly two million people each year. More information may be found at http://www.ciming.com. About Dehaier Medical Systems Ltd. Dehaier is an emerging leader in the development, marketing and sale of medical products, including medical devices and wearable sleep respiratory products. The company develops and assembles its self-branded medical devices and sleep respiratory products from third-party components. The company also distributes products designed and manufactured by other companies, including medical devices from IMD (Italy), HEYER (Germany) and Timesco (UK). Dehaier's technology is based on six patents and eleven software copyrights. More information may be found at http://www.dehaier.com.cn. Forward-looking Statements This news release contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements that are other than statements of historical facts. These statements are subject to uncertainties and risks including, but not limited to, product and service demand and acceptance, fulfillment of bids and contracts, changes in technology, economic conditions, the impact of competition and pricing, government regulation, and other risks contained in reports filed by the company with the Securities and Exchange Commission. All such forward-looking statements, whether written or oral, and whether made by or on behalf of the company, are expressly qualified by the cautionary statements and any other cautionary statements which may accompany the forward-looking statements. In addition, the company disclaims any obligation to update any forward-looking statements to reflect events or circumstances after the date hereof.
CONTACT: For more information, please contact: Dehaier Medical Systems Limited Janice Wang +86 10-5166-0080 firstname.lastname@example.org Weitian Investor Relations Tina Xiao +1-917-609-0333 Tina.email@example.com